Where the stock stands
Abbott India Ltd. (ABBOTINDIA) is a Healthcare-sector listing, and the latest print in Strota's record has it at ₹27,270, up 5.25% from a previous close of ₹25,910. That stood well clear of the broader market, with the Nifty up 0.33%. One caveat first: the technicals block here is stamped 17 September and built on a close of ₹25,910, so every technical figure below describes the position before that jump.
On that basis, the stock sat 17.37% below its 52-week high of ₹31,355 and 3.08% above its 52-week low of ₹25,135 — nearer the bottom of its yearly range than the top. Trailing returns say the same thing another way: up 2.71% over a week, down 2.5% over a month, down 1.1% over three months, and down 16.1% over a year. On valuation, the pack records a price-to-earnings ratio of 35.87, a price-to-book of 12.14, earnings per share of ₹760.24, a market capitalisation of ₹57,947 crore and a dividend yield of 1.93%.
What the smart-money flow shows
Nothing — and that is worth stating plainly rather than dressing up. Strota's record for this stock carries no F&O positioning at all: no long buildup or short buildup, so no read on whether fresh futures positions were opened as the price moved. There are no disclosed bulk or block deals, the large single trades exchanges publish by name, no institutional buying or selling streak, and no insider filings.
That absence is a statement about what has been disclosed and captured, not evidence that nothing happened. It does not mean no large investor bought or sold this stock; it means nothing of the sort came through the channels this site tracks. The consequence for a reader is that the usual cross-check — does the flow agree with the price? — is unavailable here, and the price action has to be read on its own.
The technical picture
At the last reading the stock was below both its 50-day and its 200-day moving average, and the pack flags neither a golden cross nor a death cross, so those averages have not crossed either way recently. The 14-day RSI, a momentum gauge whose midpoint marks the balance between buying and selling pressure, stood at 44 — below that midpoint, soft without being stretched.
Relative volume was 0.67, meaning the session traded at roughly two-thirds of its usual activity. That is the pack's clearest internal contradiction: a quiet, below-midpoint momentum snapshot sits directly alongside a 5.25% single-day gain. Both can be true, since the technicals describe the earlier session, but they are not one coherent picture, and the volume behind the jump itself is not in the data.
Catalysts and what to watch
The pack carries no structured catalyst record — no scheduled events, no corporate actions. It does carry six headlines, most of them commentary rather than news: two Univest pieces on price action, metrics and valuation, and a MarketsMojo note whose own title describes technical momentum shifting amid mixed indicator signals, which matches the reading above without explaining it.
The two business-standard.com items are session-streak reports pointing opposite ways: one from about a month ago reported a fifth straight down session, one from three days ago a third straight up session. The only event-shaped item is a report from cnbctv18.com, roughly five weeks old, describing first-quarter net profit rising 17% on revenue growth of 4%.
So the data establishes this much: the stock gained 5.25% in a session, on technicals that had been soft and quiet the day before, and it sits near the lower end of its 52-week range, down 16.1% over a year. What it does not establish is why. There is no flow record, no catalyst record, and no headline dated to the move itself. A reader looking here for that day's driver will not find one.